Steering Committee

Sven Bölte, Ph.D., is professor of child and adolescent psychiatric science at the Department of Women’s and Children’s Health, Karolinska Institutet (KI), and senior clinical psychologist at the Division of Child and Adolescent Psychiatry, Center for Psychiatry Research, Region Stockholm, Sweden. He is director of the KI Center of Neurodevelopmental Disorders (“KIND”), and editor in chief of the Scandinavian Journal of Child and Adolescent Psychology and Psychiatry, He is founder of the Scientific Society Autism Spectrum (wgas.org) and international ADOS and ADI-R trainer. For his work, he has received several recognitions, such as the ”Life Watch Nordiska Priset”, ”Årets Ljus” (Society Attention), Psynk award GNET” (Sweden’s Municipalities & Regions), Autism CRC (Australia) Achievement in Autism Research and ”Fellow of the International Society for Autism Research” (INSAR). Among his commissions of trust are appointments at the Swedish Research Council, the European Network of Hyperkinetic Disorders, the National Society Attention scientific board, the Swedish Autism and Asperger Society, the Swedish Psychiatry Foundation, Swedish National Board of Institutional Care, and the National Agency for Special Needs Education and Schools. Professor Bölte has 30 years of clinical research experience and has published more than 500 original articles, reviews, book chapters, assessment and intervention tools in the field of autism, ADHD, and other neurodevelopmental conditions, with > 32,000 citations (H-index 87).

Jonna Kuntsi is Professor of Developmental Disorders and Neuropsychiatry at the Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London. She first joined the Centre as a Lecturer, following training (BSc, MSc, PhD) and positions at University College London and the Great Ormond Street Hospital for Children. Her research focuses on ADHD and other conditions and traits that often co-occur with ADHD. A major focus currently is the ADHD Remote Technology (ART) research programme, for which Jonna and team have received £4 million funding from the UK Medical Research Council and European Commission for projects on a range of topics (e.g. ADHD transition; cardiometabolic risk factors and medication adherence in adults with ADHD). In addition to being EUNETHYDIS Co-Chair, she is on the steering committee/Principal Investigator in several other international research networks, including the International Multi-centre Persistent ADHD Collaboration ‘IMpACT’, the ECNP ADHD across the Lifespan Network and the ECNP Digital Health Applied to the Clinical Research of Brain Disorders Network. She actively collaborates with patient support organisations, including ADHD Europe and the UK ADHD Information and Support Service (ADDISS), and with SMEs, such as Empatica and The Hyve.

Tobias Banaschewski MD, PhD, is Professor of Child and Adolescent Psychiatry at the Medical Faculty Mannheim of the University of Heidelberg, Medical Director of the Department of Child and Adolescent Psychiatry of the Central Institute of Mental Health (CIMH), as well as and Deputy Director of the CIMH in Mannheim, Germany. Dr. Banaschewski studied psychology and medicine at the University of Marburg in Germany. He worked as Clinical Assistant in Adult Psychiatry in Marburg and as Clinical and Research Assistant in Child & Adolescent Psychiatry at the University of Göttingen.

Pieter Hoekstra holds the Chair of Child and Adolescent Psychiatry at the University of Groningen, The Netherlands. He is also the current director of the Accare Child Study Center that focus its scientific efforts on the treatment and etiology of child-onset mental disorders. Pieter is also practicing child and adolescent at the tic disorders and ADHD outpatient clinic of Accare in Groningen. And he is editor in chief of European Child and Adolescent Psychiatry.
He studies the effectiveness of treatments for ADHD and comorbid disorders, both pharmacological treatments and psychosocial treatments. Other research efforts are directed at the etiology and causes of ADHD, using neuroimaging, neurocognition and epidemiological approaches (into the role of genetics and gene* environment interactions). It is Pieter’s ultimate to improve the diagnosis, monitoring, and treatment of psychiatric disorders. He has published over 355 peer-reviewed articles and book chapters and is one of the top-experts on ADHD according to Expertscape.

Samuele Cortese MD, PhD is currently Full Professor of Child and Adolescent Psychiatry at the University of Southampton and Honorary Consultant Child and Adolescent Psychiatrist for Solent NHS Trust. He is also Adjunct Full Professor with the New York University (NYU) and Full Professor at the University of Bari, Italy. His research focuses on neurodevelopmental disorders, in particular ADHD. He is the chair of the European ADHD Guidelines Group.
In 2022, he ranked #1 worldwide in terms of expertise on Attention-Deficit/Hyperactivity Disorder (ADHD) according to Expertscape.

Professor Dave Coghill is the Financial Markets Foundation Chair of Developmental Mental Health at the University of Melbourne, Professor of Child and Youth Psychiatry at the Royal Children's Hospital Melbourne and Orygen Youth Health. He is the President of the Australian ADHD Professionals Association. Dave has a broad research portfolio focussed on ADHD and neurodevelopmental conditions with a particular focus on cognition, psychopharmacology, evidence based clinical pathways, and measurement-based care.

Diane Purper-Ouakil is a Professor of child and adolescent psychiatry at the University Hospital of Montpellier, France. She has been head of the child and adolescent unit of the Saint Eloi Hospital since 2011. This unit has inpatient and outpatient care facilities for young patients with different mental health conditions and has specialized services for ADHD, trauma-related and eating disorders. Diane Purper-Ouakil is the president of the newly founded French Society of ADHD, an organisation for health professionals involved in clinical practice, optimisation of care trajectories and research. She has recently joined the steering committee of Eunethydis and is also the co-lead of the ECNP child and adolescent network. Diane Purper-Ouakil aims to develop the evidence base of psychological, neurophysiological and pharmacological treatments, especially for children and adolescents with challenging and enduring behavioural and emotional symptoms. She is involved in treatment studies assessing several types of interventions. Her current research focuses on parent programs, innovations in healthcare trajectories, and digital interventions, that can contribute to comprehensive treatment plans for young people with complex needs.

Kate Langley is Reader at the School of Psychology, Cardiff University, Cardiff, UK. Kate’s work investigates our understanding of ADHD and associated difficulties and how this changes across child and adolescent development, encompassing how we define and recognise ADHD, the role of genetics and other relevant factors. Kate joined the EUNETHYDIS steering committee in September 2023.

Dr. Friederike Blume is a postdoctoral researcher at DIPF | Leibniz Institute for Research and Information in Education in Frankfurt, Germany. After obtaining a teaching degree, she earned her PhD in Psychology at the LEAD Graduate School & Research Network at the University of Tübingen, where she investigated non-pharmacological interventions for children with ADHD (e.g., NIRS-based neurofeedback, classroom-based interventions). Her current work is focused on the role of the school context in shaping the development of students’ self-regulation and thus the reduction of ADHD symptoms. She has a strong methodological focus on intensive longitudinal data collection in real-life settings (i.e., ambulatory assessment) and multilevel modelling. At EUNETHYDIS, Friederike is particularly committed to the promotion of early career researchers.